Vor Biopharma Inc.

VOR

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001817229

SEC filings (opens in a new tab)

In the last 90 days, Vor Biopharma Inc. insiders filed 0 open-market purchases and 1 sale; 102 institutions reported holding it in 13F filings for Q2 2026, worth $893.0M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Vor Biopharma Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025 All holders in Q3 2025

13F holders of VOR: Q3 2025 compared with Q4 2025
Measure	Q3 2025	Q4 2025	Change
Holders	37	55	+18
Shares	3.76M	25.5M	+21.8M (+578.7%)
Value	$183.4M	$332.0M	+$148.6M (+81.1%)

New holders (28)

Institutions that held Vor Biopharma Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to VOR in Q4 2025
Institution	Shares	Value	% of portfolio
Frazier Life Sciences Management, L.P.	2,543,939	$33.3M	0.89%
Paradigm Biocapital Advisors LP	1,750,000	$22.9M	0.61%
Great Point Partners LLC	1,370,107	$17.9M	5.81%
NEXTBio Capital Management LP	999,967	$13.1M	7.67%
Caligan Partners LP	925,067	$9.96M	0.91%
Sphera Funds Management Ltd.	410,417	$5.37M	1.12%
Laurion Capital Management LP	317,243	$4.15M	0.28%
Findell Capital Management LLC	231,000	$3.02M	1.00%
Tudor Investment Corp Et Al	167,673	$2.19M	0.01%
Ameriprise Financial Inc	163,061	$2.13M	0.00%
Logos Global Management LP	100,000	$1.31M	0.09%
Northern Trust Corp	38,946	$509.4K	0.00%
Engineers Gate Manager LP	28,204	$368.9K	0.00%
Quadrature Capital Ltd	26,791	$350.4K	0.00%
Omers Administration Corp	20,700	$270.8K	0.00%
XTX Topco Ltd	17,542	$229.4K	0.01%
Independent Financial Group, LLC	17,000	$222.4K	0.00%
Susquehanna International Group, LLP	14,819	$193.8K	0.00%
Persistent Asset Partners Ltd	10,798	$141.2K	0.07%
Shay Capital LLC	10,745	$140.5K	0.02%
Susquehanna Portfolio Strategies, LLC	10,207	$133.5K	0.00%
Chung Wu Investment Group, LLC	8,300	$108.6K	0.09%
Citigroup Inc	6,340	$82.9K	0.00%
Hudson Bay Capital Management LP	5,110	$66.8K	0.00%
China Universal Asset Management Co., Ltd.	2,746	$35.9K	0.00%
Barclays PLC	1,399	$18.3K	0.00%
Mirae Asset Global Investments Co., Ltd.	819	$10.7K	0.00%
GF Fund Management Co. Ltd.	330	$4.32K	0.00%

Sold out (10)

Institutions that held Vor Biopharma Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of VOR in Q4 2025
Institution	Shares, Q3 2025	Value, Q3 2025
Ariose Capital Management Ltd	110,173	$5.37M
Tang Capital Management LLC	50,000	$2.44M
Woodline Partners LP	27,363	$1.33M
Polymer Capital Management (HK) LTD	21,248	$1.04M
Renaissance Technologies LLC	14,600	$711.3K
Virtu Financial LLC	8,104	$395.0K
Bridgeway Capital Management, LLC	6,250	$304.5K
Scientech Research LLC	6,097	$297.0K
Trustees of Columbia University in the City of New York	4,595	$223.9K
Caitong International Asset Management Co., Ltd	110	$5.36K